{"id":43513,"date":"2023-11-20T03:34:52","date_gmt":"2023-11-20T09:34:52","guid":{"rendered":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/calgb50303-pub\/"},"modified":"2024-10-30T20:39:09","modified_gmt":"2024-10-31T01:39:09","slug":"calgb50303-pub","status":"publish","type":"tcia_citation","link":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/calgb50303-pub\/","title":{"rendered":"CALGB50303-PUB"},"template":"","class_list":["post-43513","tcia_citation","type-tcia_citation","status-publish"],"tcia_citation_type":"Publication Citation","tcia_citation_text":"<p>Bartlett, N. L., Wilson, W. H., Jung, S.-H., Hsi, E. D., Maurer, M. J., Pederson, L. D., Polley, M.-Y. C., Pitcher, B. N., Cheson, B. D., Kahl, B. S., Friedberg, J. W., Staudt, L. M., Wagner-Johnston, N. D., Blum, K. A., Abramson, J. S., Reddy, N. M., Winter, J. N., Chang, J. E., Gopal, A. K., \u2026 Leonard, J. P. (2019). <strong>Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance\/CALGB 50303<\/strong>. Journal of Clinical Oncology, 37(21), 1790\u20131799. <a href=\"https:\/\/doi.org\/10.1200\/jco.18.01994\">https:\/\/doi.org\/10.1200\/jco.18.01994<\/a><\/p>\n","tcia_citation_statement":"","tcia_citation_doi":"10.1200\/jco.18.01994","_links":{"self":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations\/43513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations"}],"about":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/types\/tcia_citation"}],"wp:attachment":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/media?parent=43513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}